Purchase Now Nuparp (Rucaparib 300 mg Tablet) Online - GlobMedIndia in India.

Nuparp (Rucaparib 300 mg Tablet)

Nuparp 300 mg Tablet contains Rucaparib, a targeted cancer therapy belonging to the class of PARP (Poly ADP-Ribose Polymerase) inhibitors. It is mainly used in oncology for treating certain types of cancers linked with BRCA gene mutations and defects in DNA repair mechanisms.

Rucaparib works by blocking the PARP enzyme, preventing cancer cells from repairing their damaged DNA, ultimately leading to their death while slowing tumor progression.

Composition & Content

• Active ingredient: Rucaparib 300 mg
• Drug class: PARP inhibitor (antineoplastic agent)
• Form: Oral tablet

Uses & Therapeutic Applications

Nuparp (Rucaparib) is commonly prescribed in:

• Ovarian cancer (especially recurrent or advanced cases)
• Fallopian tube cancer
• Primary peritoneal cancer
• Maintenance therapy in BRCA-mutated cancers
• In some cases, prostate cancer with HRR gene mutations

How It Works

Rucaparib blocks the PARP enzyme, which cancer cells use to repair DNA damage. Without this repair mechanism, cancer cells accumulate damage and die, helping slow or stop tumor growth.

Dosage & Administration

• Dose is determined strictly by an oncologist
• Common regimen: oral intake twice daily (as prescribed)
• Should be taken with or without food
• Tablets must be swallowed whole (not crushed or chewed)

⚠️ Never self-adjust dosage without medical supervision.

Side Effects

Common effects may include:

• Nausea or vomiting
• Fatigue
• Loss of appetite
• Anemia
• Abdominal discomfort

Serious side effects require immediate medical attention.

Advantages of Rucaparib Therapy

• Targeted cancer treatment (precision medicine)
• Effective in BRCA-mutated cancers
• Helps delay disease progression
• Oral administration (no hospitalization needed for dosing)

Storage Conditions

• Store at room temperature (20°C–25°C)
• Keep in a dry place away from moisture
• Protect from direct sunlight
• Keep out of reach of children

Alternative PARP Inhibitors (Class Alternatives)

If Rucaparib is not suitable or available, doctors may consider:

• Olaparib
• Niraparib
• Talazoparib

⚠️ Substitution should only be done by an oncologist based on genetic and clinical evaluation.

Important Note

Rucaparib is a prescription-only anticancer medicine. It must be used strictly under the guidance of a qualified oncologist after proper diagnostic testing.